Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides.

Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Arlehamn CSL, Sette A.

Nature. 2017 Sep 13;549(7671):292. doi: 10.1038/nature23896.

PMID:
28905919
2.

T cells from patients with Parkinson's disease recognize α-synuclein peptides.

Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A.

Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21. Erratum in: Nature. 2017 Sep 13;549(7671):292.

3.

Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.

Bancroft T, Dillon MB, da Silva Antunes R, Paul S, Peters B, Crotty S, Lindestam Arlehamn CS, Sette A.

Cell Immunol. 2016 Jun-Jul;304-305:35-43. doi: 10.1016/j.cellimm.2016.05.002. Epub 2016 May 14.

4.

T-cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome.

Bresciani A, Paul S, Schommer N, Dillon MB, Bancroft T, Greenbaum J, Sette A, Nielsen M, Peters B.

Immunology. 2016 May;148(1):34-9. doi: 10.1111/imm.12585. Epub 2016 Feb 8.

5.

The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.

Mothé BR, Lindestam Arlehamn CS, Dow C, Dillon MBC, Wiseman RW, Bohn P, Karl J, Golden NA, Gilpin T, Foreman TW, Rodgers MA, Mehra S, Scriba TJ, Flynn JL, Kaushal D, O'Connor DH, Sette A.

Tuberculosis (Edinb). 2015 Dec;95(6):722-735. doi: 10.1016/j.tube.2015.07.005. Epub 2015 Aug 28.

6.

Different Bla-g T cell antigens dominate responses in asthma versus rhinitis subjects.

Dillon MB, Schulten V, Oseroff C, Paul S, Dullanty LM, Frazier A, Belles X, Piulachs MD, Visness C, Bacharier L, Bloomberg GR, Busse P, Sidney J, Peters B, Sette A.

Clin Exp Allergy. 2015 Dec;45(12):1856-67. doi: 10.1111/cea.12643.

7.

A population response analysis approach to assign class II HLA-epitope restrictions.

Paul S, Dillon MBC, Arlehamn CSL, Huang H, Davis MM, McKinney DM, Scriba TJ, Sidney J, Peters B, Sette A.

J Immunol. 2015 Jun 15;194(12):6164-6176. doi: 10.4049/jimmunol.1403074. Epub 2015 May 6.

8.

Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes.

Paul S, Lindestam Arlehamn CS, Scriba TJ, Dillon MB, Oseroff C, Hinz D, McKinney DM, Carrasco Pro S, Sidney J, Peters B, Sette A.

J Immunol Methods. 2015 Jul;422:28-34. doi: 10.1016/j.jim.2015.03.022. Epub 2015 Apr 7.

9.

Automethylation of protein arginine methyltransferase 8 (PRMT8) regulates activity by impeding S-adenosylmethionine sensitivity.

Dillon MB, Rust HL, Thompson PR, Mowen KA.

J Biol Chem. 2013 Sep 27;288(39):27872-80. doi: 10.1074/jbc.M113.491092. Epub 2013 Aug 14.

10.

Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.

Dillon MB, Bachovchin DA, Brown SJ, Finn MG, Rosen H, Cravatt BF, Mowen KA.

ACS Chem Biol. 2012 Jul 20;7(7):1198-204. doi: 10.1021/cb300024c. Epub 2012 Apr 20.

11.

Skin as a potential source of infectious foot and mouth disease aerosols.

Dillon MB.

Proc Biol Sci. 2011 Jun 22;278(1713):1761-9. doi: 10.1098/rspb.2010.2430. Epub 2011 Mar 30. Review.

12.

Quantitative reactivity profiling predicts functional cysteines in proteomes.

Weerapana E, Wang C, Simon GM, Richter F, Khare S, Dillon MB, Bachovchin DA, Mowen K, Baker D, Cravatt BF.

Nature. 2010 Dec 9;468(7325):790-5. doi: 10.1038/nature09472. Epub 2010 Nov 17.

13.

The role of deposition in limiting the hazard extent of dense-gas plumes.

Dillon MB.

J Hazard Mater. 2009 May 30;164(2-3):1293-303. doi: 10.1016/j.jhazmat.2008.09.044. Epub 2008 Sep 21.

PMID:
18976854
14.

Interfacing with Community Mental Health Services: Opportunities for Occupational Therapy and Level II Fieldwork Education.

Dillon MB, Dillon TH, King RM, Chamberlin JL.

Occup Ther Health Care. 2007;21(1-2):91-104. doi: 10.1080/J003v21n01_07.

PMID:
23926971
15.

Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.

McLellan R, Dillon MB, Woodruff JD, Heatley GJ, Fields AL, Rosenshein NB.

Gynecol Oncol. 1994 Feb;52(2):253-9.

PMID:
8314148
16.

High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.

Hunter RE, Griffin TW, Stevens S, Roman LD, Bokhari F, Reale FR, Tak WK, Fitzgerald TJ, Dillon MB, Rose PG.

Cancer. 1991 Nov 1;68(9):1890-4.

PMID:
1655227
17.

Ultrasonic surgical aspiration in the treatment of vulvar disease.

Rader JS, Leake JF, Dillon MB, Rosenshein NB.

Obstet Gynecol. 1991 Apr;77(4):573-6.

PMID:
2002980
18.

Peritoneal cytology in endometrial cancer: a review.

McLellan R, Dillon MB, Currie JL, Rosenshein NB.

Obstet Gynecol Surv. 1989 Oct;44(10):711-9. Review.

PMID:
2677857
19.

Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer.

Hunter RE, Doherty P, Griffin TW, Gionet M, Hnatowich DJ, Bianco JA, Dillon MB.

Gynecol Oncol. 1987 Jul;27(3):325-39.

PMID:
3497845
20.

Prophylactic topical cefamandole in radical hysterectomy.

Miyazawa K, Hernandez E, Dillon MB.

Int J Gynaecol Obstet. 1987 Apr;25(2):133-8.

PMID:
2884138
21.

Peritoneal cytology in stage I endometrial cancer.

Hernandez E, Rosenshein NB, Dillon MB, Villar J.

J Natl Med Assoc. 1985 Oct;77(10):799-803.

22.

A prospective randomized study of doxycycline as a prophylactic antibiotic in patients undergoing radical hysterectomy.

Rosenshein NB, Ruth JC, Villar J, Grumbine FB, Dillon MB, Spence MR.

Gynecol Oncol. 1983 Apr;15(2):201-6.

PMID:
6339331
23.

Alternating multiagent chemotherapy for advanced ovarian cancer.

Hernandez E, Rosenshein NB, Villar J, Dillon MB, Ettinger DS, Order SE.

J Surg Oncol. 1983 Feb;22(2):87-91.

PMID:
6296547
24.

Ip immunotherapy and chemotherapy in advanced epithelial ovarian cancer.

Hernandez E, Rosenshein NB, Pino y Torres J, Villar J, Grumbine FC, Ettinger DS, Dillon MB, Klein JL, Order SE.

Cancer Treat Rep. 1982 Nov;66(11):1981-2.

PMID:
7139641
25.

Prevention of endomyometritis using antibiotic irrigation during cesarean section.

Rudd EG, Cobey EA, Long WH, Dillon MB, Matthews MD.

Obstet Gynecol. 1982 Oct;60(4):413-6.

PMID:
6750473
26.

Febrile morbidity following cefamandole nafate intrauterine irrigation during cesarean section.

Rudd EG, Long WH, Dillon MB.

Am J Obstet Gynecol. 1981 Sep 1;141(1):12-6.

PMID:
7270617
27.

The diagnosis and management of cervical intraepithelial neoplasia in the patient under the age of twenty-one.

Dillon MB, Rosenshein NB, Parmley TH, Ruth J, Grumbine FC, Gupta PK.

Int J Gynaecol Obstet. 1981 Apr;19(2):97-102.

PMID:
6119251
28.

Intrauterine irrigation with cefamandole nafate solution at cesarean section: a preliminary report.

Long WH, Rudd EG, Dillon MB.

Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 1):755-8.

PMID:
7446607
29.

Single-dose and multidose prophylaxis in vaginal hysterectomy: a comparison of sodium cephalothin and metronidazole.

Hamod KA, Spence MR, Rosenshein NB, Dillon MB.

Am J Obstet Gynecol. 1980 Apr 15;136(8):976-9.

PMID:
6989245
30.

New methods applied to the analysis and treatment of ovarian cancer.

Order SE, Rosenshein NB, Klein JL, Lichter AS, Ettinger DS, Dillon MB, Leibel SA.

Int J Radiat Oncol Biol Phys. 1979 Jun;5(6):861-73. No abstract available.

PMID:
500415
31.

The use of custom molds for intracavitary treatment of carcinoma of the cervix.

Lichter AS, Dillon MB, Rosenshein NB, Order SE.

Int J Radiat Oncol Biol Phys. 1978 Sep-Oct;4(9-10):873-9. No abstract available.

PMID:
711558

Supplemental Content

Loading ...
Support Center